Company / Return on Assets (ROA)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. Return on Assets (ROA) History
FY2011-FY2015 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-462.6%
FY2015
5-year range
-462.6% / -0.9%
FY2011-FY2015
Trend
-15906.6%
vs FY2014
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) changed -15907% YoY in FY2015, a notable deviation from the 3-year average annual change of -5348%.
Based on SEC 10-K filings.
-462.6% in FY2015 with a 3-year CAGR of -461.7%.
Declined from -0.9% to -462.6% over the past 3 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -461.7pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2015, return on assets (roa) decreased 15906.6% year-over-year.
Company context
Key Data Points
- Altman Z-Score -11.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2015 | -462.6% | -15906.6% |
| FY2013 | -2.9% | -214.1% |
| FY2012 | -0.9% | +75.5% |
| FY2011 | -3.8% | - |
As of FY2015 · SEC 10-K · Updated Jun 24, 2026